452 related articles for article (PubMed ID: 21702907)
1. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.
Hondow HL; Fox SB; Mitchell G; Scott RJ; Beshay V; Wong SQ; ; Dobrovic A
BMC Cancer; 2011 Jun; 11():265. PubMed ID: 21702907
[TBL] [Abstract][Full Text] [Related]
2. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.
Takano EA; Mitchell G; Fox SB; Dobrovic A
BMC Cancer; 2008 Feb; 8():59. PubMed ID: 18298804
[TBL] [Abstract][Full Text] [Related]
3. High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families.
Riahi A; Kharrat M; Lariani I; Chaabouni-Bouhamed H
Fam Cancer; 2014 Dec; 13(4):603-9. PubMed ID: 25069718
[TBL] [Abstract][Full Text] [Related]
4. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
[TBL] [Abstract][Full Text] [Related]
5. High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.
de Juan I; Esteban E; Palanca S; Barragán E; Bolufer P
Breast Cancer Res Treat; 2009 May; 115(2):405-14. PubMed ID: 18528753
[TBL] [Abstract][Full Text] [Related]
6. A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.
Coulet F; Pires F; Rouleau E; Lefol C; Martin S; Colas C; Cohen-Haguenauer O; Giurgea I; Fajac A; Noguès C; Demange L; Hardouin A; Lidereau R; Soubrier F
Genet Test Mol Biomarkers; 2010 Oct; 14(5):677-90. PubMed ID: 20858050
[TBL] [Abstract][Full Text] [Related]
7. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
[TBL] [Abstract][Full Text] [Related]
8. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 mutation screening using SmartCycler II high-resolution melt curve analysis.
Dufresne SD; Belloni DR; Wells WA; Tsongalis GJ
Arch Pathol Lab Med; 2006 Feb; 130(2):185-7. PubMed ID: 16454559
[TBL] [Abstract][Full Text] [Related]
10. Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.
Valarmathi MT; Sawhney M; Deo SSV; Shukla NK; Das SN
Hum Mutat; 2004 Feb; 23(2):205. PubMed ID: 14722926
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Seo JH; Cho DY; Ahn SH; Yoon KS; Kang CS; Cho HM; Lee HS; Choe JJ; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Son GS; Lee JB; Koo BH
Hum Mutat; 2004 Oct; 24(4):350. PubMed ID: 15365993
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls and caveats in BRCA sequencing.
Bellosillo B; Tusquets I
Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125
[TBL] [Abstract][Full Text] [Related]
14. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
[TBL] [Abstract][Full Text] [Related]
15. High-throughput resequencing in the diagnosis of BRCA1/2 mutations using oligonucleotide resequencing microarrays.
Schroeder C; Stutzmann F; Weber BH; Riess O; Bonin M
Breast Cancer Res Treat; 2010 Jul; 122(1):287-97. PubMed ID: 19941162
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.
Tazzite A; Jouhadi H; Nadifi S; Aretini P; Falaschi E; Collavoli A; Benider A; Caligo MA
Gynecol Oncol; 2012 Jun; 125(3):687-92. PubMed ID: 22425665
[TBL] [Abstract][Full Text] [Related]
17. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
[TBL] [Abstract][Full Text] [Related]
18. Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany.
Hamann U; Liu X; Bungardt N; Ulmer HU; Bastert G; Sinn HP
Eur J Hum Genet; 2003 Jun; 11(6):464-7. PubMed ID: 12774040
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner.
van der Stoep N; van Paridon CD; Janssens T; Krenkova P; Stambergova A; Macek M; Matthijs G; Bakker E
Hum Mutat; 2009 Jun; 30(6):899-909. PubMed ID: 19370767
[TBL] [Abstract][Full Text] [Related]
20. EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients.
Caux-Moncoutier V; Castéra L; Tirapo C; Michaux D; Rémon MA; Laugé A; Rouleau E; De Pauw A; Buecher B; Gauthier-Villars M; Viovy JL; Stoppa-Lyonnet D; Houdayer C
Hum Mutat; 2011 Mar; 32(3):325-34. PubMed ID: 21120943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
